Export 2747 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
D. Weisdorf, Carter, S., Confer, D., Ferrara, J., M, H., ,, and Network, M. Transplant, “Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered Questions”, Biol Blood Marrow Transplant, vol. 13, pp. 257-262, 2007.
D. J. Weisdorf, Hurd, D., Carter, S., Howe, C., Jensen, L. Ann, Wagner, J., Stablein, D., Thompson, J., and Kernan, N. A., “Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review.”, Biol Blood Marrow Transplant, vol. 9, no. 8, pp. 512-8, 2003.
P. A. Wetzel, Lindblad, A. S., Raizada, H., James, N., Mulatya, C., Kannan, M. A., Villamar, Z., Gitchel, G. T., and Weaver, L. K., “Eye Tracking Results in Postconcussive Syndrome Versus Normative Participants.”, Invest Ophthalmol Vis Sci, vol. 59, no. 10, pp. 4011-4019, 2018.
S. M. Whitcup, Fortin, E., Lindblad, A. S., Griffiths, P., Metcalf, J. A., Robinson, M. R., Manischewitz, J., Baird, B., Perry, C., Kidd, I. M., Vrabec, T., Davey, R. T., Falloon, J., Walker, R. E., Kovacs, J. A., Lane, H. C., Nussenblatt, R. B., Smith, J., Masur, H., and Polis, M. A., “Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.”, JAMA, vol. 282, no. 17, pp. 1633-7, 1999.
S. M. Whitcup, Fortin, E., Lindblad, A. S., Griffiths, P., Metcalf, J. A., Robinson, M. R., Manischewitz, J., Baird, B., Perry, C., Kidd, I. M., Vrabec, T., Davey, R. T., Falloon, J., Walker, R. E., Kovacs, J. A., Lane, H. C., Nussenblatt, R. B., Smith, J., Masur, H., and Polis, M. A., “Discontinuation of ant cytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis”, JAMA, vol. 282, pp. 1633-37, 1999.
T. L. Whiteside, Griffin, D. L., Stanson, J., Gooding, W., McKenna, D., Sumstad, D., Kadidlo, D., Gee, A., Durett, A., Lindblad, R., Wood, D., and Styers, D., “Shipping of therapeutic somatic cell products.”, Cytotherapy, vol. 13, no. 2, pp. 201-13, 2011.
T. Whiteside, Griffin, D., Stanson, J., Gooding, W., McKenna, D., Sumstad, D., Kadidlo, D., Gee, A., Durett, A., Lindblad, R., Wood, D., and Styers, D., “Shipping of Therapeutic Somatic Cell Products”, Cytotherapy, vol. 13, pp. 201-213, 2011.
S. Whittier, Au, A., Sarraf, D., Oden, N., VanVeldhuisen, P., Scott, I., Ip, M., Watson, S., Blodi, B., and Domalpally, A., “Reproducibility of Grading Superficial vs Deep Retinal Hemorrhage in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2)”, in Association for Research in Vision and Ophthalmology Annual Meeting, 2021.
L. E. Widdice, Unger, E. R., Panicker, G., Hoagland, R., S Callahan, T., Jackson, L. A., Berry, A. A., Kotloff, K., Frey, S. E., Harrison, C. J., Pahud, B. A., Edwards, K. M., Mulligan, M. J., Sudman, J., and Bernstein, D. I., “Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.”, Vaccine, vol. 36, no. 6, pp. 881-889, 2018.
L. E. Widdice, Hoagland, R., S Callahan, T., Kahn, J. A., Harrison, C. J., Pahud, B. A., Frey, S. E., Berry, A. A., Kotloff, K. L., Edwards, K. M., Mulligan, M. J., Sudman, J., Nakamura, A., and Bernstein, D. I., “Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.”, Vaccine, vol. 36, no. 11, pp. 1491-1499, 2018.
L. Wieczorek, Peachman, K., Adams, D. J., Barrows, B., Molnar, S., Schoen, J., Dawson, P., Bryant, C., Chenine, A. - L., Sanders-Buell, E., Srithanaviboonchai, K., Pathipvanich, P., Michael, N. L., Robb, M. L., Tovanabutra, S., Rao, M., and Polonis, V. R., “Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand.”, Virology, vol. 548, pp. 152-159, 2020.
J. L. Wiggs, Yaspan, B. L., Hauser, M. A., Kang, J. H., R Allingham, R., Olson, L. M., Abdrabou, W., Fan, B. J., Wang, D. Y., Brodeur, W., Budenz, D. L., Caprioli, J., Crenshaw, A., Crooks, K., Delbono, E., Doheny, K. F., Friedman, D. S., Gaasterland, D., Gaasterland, T., Laurie, C., Lee, R. K., Lichter, P. R., Loomis, S., Liu, Y., Medeiros, F. A., McCarty, C., Mirel, D., Moroi, S. E., Musch, D. C., Realini, A., Rozsa, F. W., Schuman, J. S., Scott, K., Singh, K., Stein, J. D., Trager, E. H., VanVeldhuisen, P., Vollrath, D., Wollstein, G., Yoneyama, S., Zhang, K., Weinreb, R. N., Ernst, J., Kellis, M., Masuda, T., Zack, D., Richards, J. E., Pericak-Vance, M., Pasquale, L. R., and Haines, J. L., “Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma.”, PLoS Genet, vol. 8, no. 4, p. e1002654, 2012.
J. L. Wiggs, Yaspan, B. L., Hauser, M. A., Kang, J. H., Allingham, R. R., Olson, L. M., Abdrabou, W., Fan, B. J., Wang, D. Y., Brodeur, W., Budenz, D. L., Caprioli, J., Crenshaw, A., Crooks, K., Delbono, E., Doheny, K. F., Friedman, D. S., Gaasterland, D., Gaasterland, T., Laurie, C., and Lee, R. Kand, “Common Variants at 9p21 and 8q22 are Associated with Increased Susceptibility to Optic Nerve Degeneration in Glaucoma”, PLoS Genet, vol. 8, p. e1002654, 2012.
H. E. Wiley, Thompson, D. J. S., Bailey, C., Chew, E. Y., Cukras, C. A., Jaffe, G. J., Lee, R. W. J., Loken, E. K., Meyerle, C. B., Wong, W., and Ferris, F. L., “A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.”, Ophthalmology, vol. 123, no. 4, pp. 841-9, 2016.
H. Wiley, Bailey, C., Cukras, C., Jaffe, G., Lee, R., Loken, E., Meyerle, C., Thompson, D., Wong, W., and Ferris, F., “A Randomized 36-Week Crossover Trial Comparing Ranibizumab and Bevacizumab for Diabetic Macular Edema”, in 2015 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO), Denver, CO, 2015.
C. Williams, Weaver, L. K., Langford, D., Lindblad, A., and Wierzbicki, M. R., “Neurological Evaluations within the Brain Injury and Mechanisms of Action of Hyperbaric Oxygen (HBO2) for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) Study (BIMA)”, in Undersea and Hyperbaric Medical Society Annual Scientific Meeting; Military Health System Research Symposium, 2014.
A. D. Williams, Kanner, J., Grantz, K. L., Ouidir, M., Sheehy, S., Sherman, S., Robledo, C., and Mendola, P., “Air pollution exposure and risk of adverse obstetric and neonatal outcomes among women with type 1 diabetes.”, Environ Res, vol. 197, p. 111152, 2021.
T. Williams, Blumberg, D., Perdue, L., Woolard, N., and Moreno, O., “Incorporating Web-based Training Tools and Technology in Clinical Trials Training”, in Society for Clinical Trials (SCT) 36th Annual Meeting (2015), Arlington, VA, 2015.
S. D. Williams, Stablein, D. M., Einhorn, L. H., Muggia, F. M., Weiss, R. B., Donohue, J. P., Paulson, D. F., Brunner, K. W., Jacobs, E. M., and Spaulding, J. T., “Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer.”, N Engl J Med, vol. 317, no. 23, pp. 1433-8, 1987.
D. J. Williams, C Creech, B., Walter, E. B., Martin, J. M., Gerber, J. S., Newland, J. G., Howard, L., Hofto, M. E., Staat, M. A., Oler, R. E., Tuyishimire, B., Conrad, T. M., Lee, M. S., Ghazaryan, V., Pettigrew, M. M., Fowler, V. G., Chambers, H. F., Zaoutis, T. E., Evans, S., and W Huskins, C., “Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial”, JAMA Pediatr, vol. 176, no. 3, pp. 253-261, 2022.
A. D. Williams, Grantz, K. L., Zhang, C., Nobles, C., Sherman, S., and Mendola, P., “Ambient Volatile Organic Compounds and Racial/Ethnic Disparities in Gestational Diabetes Mellitus: Are Asian/Pacific Islander Women at Greater Risk?”, Am J Epidemiol, vol. 188, no. 2, pp. 389-397, 2019.
R. F. Willkens and Stablein, D., “Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: a 48 week controlled clinical trial.”, J Rheumatol Suppl, vol. 44, pp. 64-8, 1996.
R. F. Willkens, Sharp, J. T., Stablein, D., Marks, C., and Wortmann, R., “Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment.”, Arthritis Rheum, vol. 38, no. 12, pp. 1799-806, 1995.
J. R. Wingard, Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Baden, L. R., Gersten, I. D., Mendizabal, A. M., Leather, H. L., Confer, D. L., Maziarz, R. T., Stadtmauer, E. A., Bolaños-Meade, J., Brown, J., Dipersio, J. F., Boeckh, M., and Marr, K. A., “Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.”, Blood, vol. 116, no. 24, pp. 5111-8, 2010.
J. Wingard, Carter, S., Walsh, T., Kurtzberg, J., Small, T., Baden, L., Gersten, I., Mendizabal, A., Leather, H., Confer, D., Maziarz, R., Stadtmauer, E., Bolanos-Meade, J., Brown, J., DiPersio, J., Boeckh, M., and Marr, K., “Randomized Double-blind Trial of Fluconazole vs Voriconazole for Prevention of Invasive Fungal Infection after Allo Hematopoietic Cell Transplantation”, Blood, vol. 116, pp. 5111-5118, 2010.